Table 1. Baseline patient characteristics by trial arm in the RMI/RCOG and the SRMP arms (N=148).
| RMI/RCOG (n=73) | SRMP (n=75) | |
|---|---|---|
|
Age (years) | ||
| Mean | 62.7 (7.6) | 63.8 (8.1) |
| Range | 49–80 | 50–80 |
|
Parity
n
(%) | ||
| 0 | 22 (30%) | 27 (36%) |
| 1 | 11 (15%) | 8 (11%) |
| 2 | 20 (27%) | 19 (25%) |
| ⩾3 | 20 (27%) | 21 (28%) |
|
Time since menopause (years) | ||
| Mean | 12.5 (8.8) | 13.7 (9.3) |
| Range | 0–37 | 1–33 |
|
Current HRT use
n
(%) | ||
| Yes | 10 (14%) | 11 (15%) |
|
Past HRT use
n(%) | ||
| Yes | 12 (16%) | 19 (25%) |
| No | 49 (67%) | 45 (60%) |
| NA | 10 (14%) | 11 (15%) |
| UK | 2 (3%) | 0 |
Abbreviations: HRT=hormone replacement therapy; NA=not applicable (patients currently using HRT); RCOG=Royal College of Obstetricians and Gynaecologists guideline; RMI=Risk of Malignancy Index; SRMP=Simple Rules Management Protocol; UK=Unknown. Values are either mean (s.d.) for continuous variables or n (%) for categorical variables.